Device-assisted enteroscopy performance measures in the United Kingdom : DEEP-UK quality improvement project
Thieme. All rights reserved..
BACKGROUND: Device-assisted enteroscopy (DAE) has become a well-established diagnostic and therapeutic tool for the management of small-bowel pathology. We aimed to evaluate the performance measures for DAE across the UK against the quality benchmarks proposed by the European Society of Gastrointestinal Endoscopy (ESGE).
METHODS: We retrospectively collected data on patient demographics and DAE performance measures from electronic endoscopy records of consecutive patients who underwent DAE for diagnostic and therapeutic purposes across 12 enteroscopy centers in the UK between January 2017 and December 2022.
RESULTS: A total of 2005 DAE procedures were performed in 1663 patients (median age 60 years; 53% men). Almost all procedures (98.1%) were performed for appropriate indications. Double-balloon enteroscopy was used for most procedures (82.0%), followed by single-balloon enteroscopy (17.2%) and spiral enteroscopy (0.7%). The estimated depth of insertion was documented in 73.4% of procedures. The overall diagnostic yield was 70.0%. Therapeutic interventions were performed in 42.6% of procedures, with a success rate of 96.6%. Overall, 78.0% of detected lesions were marked with a tattoo. Patient comfort was significantly better with the use of deep sedation compared with conscious sedation (99.7% vs. 68.5%; P<0.001). Major adverse events occurred in only 0.6% of procedures.
CONCLUSIONS: Performance measures for DAE in the UK meet the ESGE quality benchmarks, with high diagnostic and therapeutic yields, and a low incidence of major adverse events. However, there is room for improvement in optimizing sedation practices, standardizing the depth of insertion documentation, and adopting marking techniques to aid in the follow-up of detected lesions.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Endoscopy - 56(2024), 3 vom: 01. März, Seite 174-181 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shiha, Mohamed G [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 01.03.2024 Date Revised 01.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1055/a-2199-7155 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM364407689 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM364407689 | ||
| 003 | DE-627 | ||
| 005 | 20240301232124.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1055/a-2199-7155 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1313.xml |
| 035 | |a (DE-627)NLM364407689 | ||
| 035 | |a (NLM)37949103 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shiha, Mohamed G |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Device-assisted enteroscopy performance measures in the United Kingdom |b DEEP-UK quality improvement project |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 01.03.2024 | ||
| 500 | |a Date Revised 01.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Thieme. All rights reserved. | ||
| 520 | |a BACKGROUND: Device-assisted enteroscopy (DAE) has become a well-established diagnostic and therapeutic tool for the management of small-bowel pathology. We aimed to evaluate the performance measures for DAE across the UK against the quality benchmarks proposed by the European Society of Gastrointestinal Endoscopy (ESGE) | ||
| 520 | |a METHODS: We retrospectively collected data on patient demographics and DAE performance measures from electronic endoscopy records of consecutive patients who underwent DAE for diagnostic and therapeutic purposes across 12 enteroscopy centers in the UK between January 2017 and December 2022 | ||
| 520 | |a RESULTS: A total of 2005 DAE procedures were performed in 1663 patients (median age 60 years; 53% men). Almost all procedures (98.1%) were performed for appropriate indications. Double-balloon enteroscopy was used for most procedures (82.0%), followed by single-balloon enteroscopy (17.2%) and spiral enteroscopy (0.7%). The estimated depth of insertion was documented in 73.4% of procedures. The overall diagnostic yield was 70.0%. Therapeutic interventions were performed in 42.6% of procedures, with a success rate of 96.6%. Overall, 78.0% of detected lesions were marked with a tattoo. Patient comfort was significantly better with the use of deep sedation compared with conscious sedation (99.7% vs. 68.5%; P<0.001). Major adverse events occurred in only 0.6% of procedures | ||
| 520 | |a CONCLUSIONS: Performance measures for DAE in the UK meet the ESGE quality benchmarks, with high diagnostic and therapeutic yields, and a low incidence of major adverse events. However, there is room for improvement in optimizing sedation practices, standardizing the depth of insertion documentation, and adopting marking techniques to aid in the follow-up of detected lesions | ||
| 650 | 4 | |a Journal Article | |
| 700 | 1 | |a Sidhu, Reena |e verfasserin |4 aut | |
| 700 | 1 | |a Lucaciu, Laura A |e verfasserin |4 aut | |
| 700 | 1 | |a Palmer-Jones, Christopher |e verfasserin |4 aut | |
| 700 | 1 | |a Ayeboa-Sallah, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Lazaridis, Nikolaos |e verfasserin |4 aut | |
| 700 | 1 | |a Eckersley, Robert |e verfasserin |4 aut | |
| 700 | 1 | |a Hiner, George E |e verfasserin |4 aut | |
| 700 | 1 | |a Maxfield, Dominic |e verfasserin |4 aut | |
| 700 | 1 | |a Shaheen, Walaa |e verfasserin |4 aut | |
| 700 | 1 | |a Abduljabbar, Duaa |e verfasserin |4 aut | |
| 700 | 1 | |a Hussain, Muhammad A |e verfasserin |4 aut | |
| 700 | 1 | |a O'Hare, Rosie |e verfasserin |4 aut | |
| 700 | 1 | |a Phull, Perminder S |e verfasserin |4 aut | |
| 700 | 1 | |a Eccles, John |e verfasserin |4 aut | |
| 700 | 1 | |a Caddy, Grant R |e verfasserin |4 aut | |
| 700 | 1 | |a Butt, Mohammed A |e verfasserin |4 aut | |
| 700 | 1 | |a Kurup, Arun |e verfasserin |4 aut | |
| 700 | 1 | |a Chattree, Amit |e verfasserin |4 aut | |
| 700 | 1 | |a Hoare, Jonathan |e verfasserin |4 aut | |
| 700 | 1 | |a Jennings, Jason |e verfasserin |4 aut | |
| 700 | 1 | |a Longcroft-Wheaton, Gaius |e verfasserin |4 aut | |
| 700 | 1 | |a Collins, Paul |e verfasserin |4 aut | |
| 700 | 1 | |a Humphries, Adam |e verfasserin |4 aut | |
| 700 | 1 | |a Murino, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Despott, Edward J |e verfasserin |4 aut | |
| 700 | 1 | |a Sanders, David S |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Endoscopy |d 1976 |g 56(2024), 3 vom: 01. März, Seite 174-181 |w (DE-627)NLM000175854 |x 1438-8812 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2024 |g number:3 |g day:01 |g month:03 |g pages:174-181 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1055/a-2199-7155 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2024 |e 3 |b 01 |c 03 |h 174-181 | ||